Anadys Pharmaceuticals Inc

CIK 1128495 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Anadys Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Feb 14, 2012SC 13G/A0001172661-12-000251
Feb 14, 2012SC 13G/A0000902664-12-000367
Dec 6, 201115-12G0001193125-11-332208
Dec 6, 2011EFFECT9999999995-11-003464
Dec 6, 2011EFFECT9999999995-11-003462
Dec 6, 2011EFFECT9999999995-11-003460
Dec 6, 2011EFFECT9999999995-11-003459
Dec 5, 2011S-8 POS0001193125-11-330178
Dec 5, 2011S-8 POS0001193125-11-330185
Dec 5, 2011S-8 POS0001193125-11-330172
Dec 5, 2011POS AM0001193125-11-330136
Dec 5, 2011S-8 POS0001193125-11-330194
Dec 5, 2011S-8 POS0001193125-11-330165
Dec 5, 2011POS AM0001193125-11-330145
Dec 5, 2011S-8 POS0001193125-11-330154
Dec 5, 2011S-8 POS0001193125-11-330202
Dec 5, 2011POS AM0001193125-11-330139
Dec 5, 2011S-8 POS0001193125-11-330208
Dec 5, 2011POS AM0001193125-11-330150
Nov 30, 20118-K0001193125-11-325909
Nov 23, 2011SC 14D9/A0001193125-11-320957
Nov 23, 2011SC TO-T/A0001193125-11-320939
Nov 23, 201125-NSE0001354457-11-000251
Nov 16, 2011SC TO-T/A0001193125-11-313278
Nov 15, 2011SC 14D9/A0001193125-11-313084